NCT03580850

Unknown

MRI Scan and Intra-labyrinthine Schwannoma

University Hospital, Strasbourg, France Source

Compare

Other study identifiers

Sponsor study identifier

6809

Study Type

observational

Estimated enrollment

30

Locations

1 country

Sites

1

Timeline

Study Start

February 2, 2018

Actual (reported)

Primary Completion

February 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

February 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 30 participants
Study completion date: February 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2, 2018
Actual (reported)
First Submitted
February 26, 2018
Actual (reported)
First Posted
July 9, 2018
Actual (reported)
Primary Completion
February 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
February 2019
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: July 13, 2018
Status Verified: February 2018
Last Update Submitted: July 11, 2018

Conditions

Schwannoma

Keywords

intra labyrinthine schwannomaschwannomamagnetic resonance imaging (MRI)gadoliniumT2 weighted gradient echo

Outcome Measures

Primary Outcomes (1)

Presence or absence of intra labyrinthine vestibular nerve tumor using T2 FIESTA alone
1 hour after the realization of the MRI

Interventions

No intervention in this restrospective studyOther

This study is an obervational study

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 80 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patient having intra-labyrinthine schwannoma

You may qualify if:

Age 18-80 years

Sponsors & Collaborators

University Hospital, Strasbourg, France
Otherlead

Study Sites (1)

Service Imagerie 1

Strasbourg, 67098, France

RECRUITING

Francis VEILLON, MD, PhDCONTACT33 3 88 12 78 65

Aïna VENKATASAMY, MDCONTACT33 3 88 12 78 65 aina.venkatasamy@chru-strasbourg.fr

Francis VEILLON, MD, PhDPRINCIPAL INVESTIGATOR

Aïna VENKATASAMY, MDSUB INVESTIGATOR

Anne KAROL, MDSUB INVESTIGATOR

MeSH Terms

Conditions

Neurilemmoma

Condition Hierarchy (Ancestors)

Neuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeuromaNerve Sheath NeoplasmsNeoplasms, Nerve Tissue

Study Officials

Francis VEILLON, MD, PhD
University Hospital, Strasbourg, France
STUDY DIRECTOR

Central Study Contacts

Francis VEILLON, MD, PhD

CONTACT

33 3 88 12 78 65 Francis.veillon@chru-strasbourg.fr

Aïna VENKATASAMY, MD

CONTACT

33 3 88 12 78 65

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 26, 2018

First Posted

July 9, 2018

Study Start

February 2, 2018

Actual (reported)

Primary Completion

February 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

NCT00603694

Hippocampal Radiation Exposure and Memory

Completed

NCT05684692

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Phase 2Recruiting

Have intra-labyrinthine schwannoma

Have benefited from an MRI with gadolinium injection on the MRI 3T with interpretable sequences of good quality

Subject giving their consent for their participation

Subjects who benefited, between 2009 and 2016, from an MRI of the external auditory canals, with gadolinous product injection and on the 3 Tesla MRI, in which a diagnosis of intra labyrinthine schwannoma was made

You may not qualify if:

\- Refusal to participate in the study

Contact the study team to confirm eligibility.

aina.venkatasamy@chru-strasbourg.fr

Study Completion

February 2019

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

July 13, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing: Will not share

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03580850
Data provider: ClinicalTrials.gov
Source updated: 2018-07-13
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:37:13 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations